Metraipolis › archive › dc_e3560fd92fb0
Identification of DNASE1L3 as a novel biomarker of clinical stage in liver hepatocellular carcinoma — Europe PMC PMID:41602546
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41602546
- DOI
- 10.3389/fmolb.2025.1681888
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T21:05:21.693Z
- SHA-256 of the archived text
511d209430745d181beb538f5054592fc6f0bd996ab75b9deb9780c009574fd7- Stable URL of this page
https://metraipolis.com/documento/dc_e3560fd92fb0
How to cite
Identification of DNASE1L3 as a novel biomarker of clinical stage in liver hepatocellular carcinoma — Europe PMC PMID:41602546 — Europe PMC (en), https://europepmc.org/article/MED/41602546 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e3560fd92fb0 (Metraipolis archive dc_e3560fd92fb0, sha256 511d209430745d181beb538f5054592fc6f0bd996ab75b9deb9780c009574fd7)
BibTeX
@misc{dce3560fd92fb0,
title = {Identification of DNASE1L3 as a novel biomarker of clinical stage in liver hepatocellular carcinoma — Europe PMC PMID:41602546},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41602546},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e3560fd92fb0; sha256 511d209430745d181beb538f5054592fc6f0bd996ab75b9deb9780c009574fd7},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41602546. Agents can read the archived copy with the MCP tool read_document.